ATE414077T1 - Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten - Google Patents
Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivatenInfo
- Publication number
- ATE414077T1 ATE414077T1 AT04736779T AT04736779T ATE414077T1 AT E414077 T1 ATE414077 T1 AT E414077T1 AT 04736779 T AT04736779 T AT 04736779T AT 04736779 T AT04736779 T AT 04736779T AT E414077 T1 ATE414077 T1 AT E414077T1
- Authority
- AT
- Austria
- Prior art keywords
- ylupiperidine
- ylamin
- benzimidazole
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48217603P | 2003-06-24 | 2003-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE414077T1 true ATE414077T1 (de) | 2008-11-15 |
Family
ID=33539339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04736779T ATE414077T1 (de) | 2003-06-24 | 2004-06-14 | Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7183414B2 (de) |
| EP (1) | EP1641780B1 (de) |
| JP (1) | JP2007516168A (de) |
| KR (2) | KR100787649B1 (de) |
| CN (1) | CN100404530C (de) |
| AR (1) | AR044849A1 (de) |
| AT (1) | ATE414077T1 (de) |
| AU (1) | AU2004249511B2 (de) |
| BR (1) | BRPI0411794A (de) |
| CA (1) | CA2529032C (de) |
| CL (1) | CL2004001470A1 (de) |
| CO (1) | CO5650165A2 (de) |
| DE (1) | DE602004017731D1 (de) |
| DK (1) | DK1641780T3 (de) |
| ES (1) | ES2315663T3 (de) |
| HK (1) | HK1089170A1 (de) |
| IL (1) | IL172064A (de) |
| MX (1) | MXPA05014203A (de) |
| NO (1) | NO20060376L (de) |
| NZ (2) | NZ571898A (de) |
| RU (1) | RU2323214C2 (de) |
| SG (1) | SG161745A1 (de) |
| TW (1) | TWI294425B (de) |
| WO (1) | WO2004113322A1 (de) |
| ZA (1) | ZA200509253B (de) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0411421D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxo Group Ltd | Novel compounds |
| JP2008515872A (ja) * | 2004-10-07 | 2008-05-15 | ファイザー・プロダクツ・インク | 抗増殖剤として有用なベンゾイミダゾール誘導体 |
| US20070021443A1 (en) * | 2005-04-05 | 2007-01-25 | Ohlmeyer Michael J | Purine and imidazopyridine derivatives for immunosuppression |
| US7504513B2 (en) | 2006-02-27 | 2009-03-17 | Hoffman-La Roche Inc. | Thiazolyl-benzimidazoles |
| ES2378513T3 (es) | 2008-08-06 | 2012-04-13 | Pfizer Inc. | Compuestos 2-heterociclilamino piracinas sustituidas en posición 6 como inhibidores de CHK-1 |
| SG172229A1 (en) | 2008-12-18 | 2011-07-28 | Hoffmann La Roche | Thiazolyl-benzimidazoles |
| CN101993416B (zh) * | 2009-08-27 | 2013-09-11 | 中国科学院上海药物研究所 | 喹啉类化合物、其制备方法、包含该化合物的药物组合物及该化合物的用途 |
| KR101738063B1 (ko) | 2012-09-21 | 2017-05-19 | 아로그 파마슈티칼스, 인코퍼레이티드 | 구조적으로 활성인 인산화된 ｆｌｔ３ 키나제의 억제 방법 |
| JP6042157B2 (ja) | 2012-09-26 | 2016-12-14 | アログ・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニーＡｒｏｇ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，ＬＬＣ | 変異型ｃ−ｋｉｔの阻害方法 |
| US10835525B2 (en) | 2012-09-26 | 2020-11-17 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
| US11642340B2 (en) | 2012-09-26 | 2023-05-09 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
| BR112015016282A2 (pt) | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals Inc | crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado |
| US10463658B2 (en) | 2013-10-25 | 2019-11-05 | Videra Pharmaceuticals, Llc | Method of inhibiting FLT3 kinase |
| BR112019008762A2 (pt) | 2016-11-02 | 2019-07-16 | Arog Pharmaceuticals Inc | método para o tratamento de um distúrbio proliferativo mutado em flt3 |
| CN107382984B (zh) * | 2017-08-24 | 2020-07-10 | 扬州市三药制药有限公司 | 一种治疗白血病药物的制备方法 |
| CN107382983B (zh) * | 2017-08-24 | 2020-08-07 | 扬州市三药制药有限公司 | 一种治疗白血病药物的合成方法 |
| CN110840893A (zh) | 2018-12-13 | 2020-02-28 | 安罗格制药有限责任公司 | 含克莱拉尼的药物组合物及其用途 |
| CN109678849A (zh) * | 2019-01-16 | 2019-04-26 | 北京悦康科创医药科技股份有限公司 | 一种抗癌药物的制备方法 |
| US11471451B2 (en) | 2019-08-19 | 2022-10-18 | Arog Pharmaceuticals, Inc. | Uses of crenolanib |
| CN117447376A (zh) * | 2019-12-09 | 2024-01-26 | 苏州恩华生物医药科技有限公司 | 连双环结构sigma-1受体抑制剂 |
| CN114981298B (zh) | 2019-12-12 | 2024-08-20 | 听治疗有限责任公司 | 用于预防和治疗听力损失的组合物和方法 |
| WO2022019998A1 (en) * | 2020-07-20 | 2022-01-27 | Arog Pharmaceuticals, Inc. | Crystal forms of crenolanib and methods of use thereof |
| CA3186319A1 (en) * | 2020-07-20 | 2022-01-27 | Arog Pharmaceuticals, Inc. | Crystal forms of crenolanib and methods of use thereof |
| AU2021320860A1 (en) * | 2020-08-05 | 2023-02-23 | The General Hospital Corporation | Salt inducible kinase inhibitors |
| US20220079934A1 (en) * | 2020-09-17 | 2022-03-17 | Arog Pharmaceuticals, Inc. | Crenolanib for treating pain |
| US11524006B2 (en) | 2020-09-17 | 2022-12-13 | Arog Pharmaceuticals, Inc. | Crenolanib for treating TRK kinase associated proliferative disorders |
| US11969420B2 (en) | 2020-10-30 | 2024-04-30 | Arog Pharmaceuticals, Inc. | Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders |
| CN113683594B (zh) * | 2021-09-07 | 2022-12-27 | 曲靖师范学院 | 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用 |
| JP2023063189A (ja) | 2021-10-22 | 2023-05-09 | アログ・ファーマシューティカルズ・インコーポレイテッド | 以前の治療に対して再発性／不応性のｆｌｔ３突然変異増殖性障害を治療するためのクレノラニブ |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE390404T1 (de) * | 1997-02-27 | 2008-04-15 | Takeda Pharmaceutical | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta |
| UA75055C2 (uk) * | 1999-11-30 | 2006-03-15 | Пфайзер Продактс Інк. | Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі |
| JP4554135B2 (ja) * | 1999-12-10 | 2010-09-29 | 富士フイルム株式会社 | インクジェットヘッドおよび印刷装置 |
| JPWO2002022549A1 (ja) * | 2000-09-14 | 2004-01-22 | 鐘淵化学工業株式会社 | ニトロベンゼンスルホニル基を除去する方法 |
| PA8580301A1 (es) * | 2002-08-28 | 2005-05-24 | Pfizer Prod Inc | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos |
-
2004
- 2004-06-14 SG SG200700254-6A patent/SG161745A1/en unknown
- 2004-06-14 BR BRPI0411794-8A patent/BRPI0411794A/pt not_active IP Right Cessation
- 2004-06-14 CA CA002529032A patent/CA2529032C/en not_active Expired - Lifetime
- 2004-06-14 CL CL200401470A patent/CL2004001470A1/es unknown
- 2004-06-14 MX MXPA05014203A patent/MXPA05014203A/es active IP Right Grant
- 2004-06-14 RU RU2005138367/04A patent/RU2323214C2/ru active
- 2004-06-14 KR KR1020057024593A patent/KR100787649B1/ko not_active Expired - Fee Related
- 2004-06-14 NZ NZ571898A patent/NZ571898A/en not_active IP Right Cessation
- 2004-06-14 JP JP2006516552A patent/JP2007516168A/ja active Pending
- 2004-06-14 DE DE602004017731T patent/DE602004017731D1/de not_active Expired - Lifetime
- 2004-06-14 AT AT04736779T patent/ATE414077T1/de not_active IP Right Cessation
- 2004-06-14 CN CNB2004800175706A patent/CN100404530C/zh not_active Expired - Lifetime
- 2004-06-14 AU AU2004249511A patent/AU2004249511B2/en not_active Ceased
- 2004-06-14 KR KR1020077019713A patent/KR20070092333A/ko not_active Withdrawn
- 2004-06-14 NZ NZ543714A patent/NZ543714A/en not_active IP Right Cessation
- 2004-06-14 WO PCT/IB2004/001983 patent/WO2004113322A1/en active Application Filing
- 2004-06-14 DK DK04736779T patent/DK1641780T3/da active
- 2004-06-14 EP EP04736779A patent/EP1641780B1/de not_active Expired - Lifetime
- 2004-06-14 ES ES04736779T patent/ES2315663T3/es not_active Expired - Lifetime
- 2004-06-22 AR ARP040102160A patent/AR044849A1/es unknown
- 2004-06-23 US US10/875,030 patent/US7183414B2/en not_active Expired - Lifetime
- 2004-06-23 TW TW093118112A patent/TWI294425B/zh not_active IP Right Cessation
-
2005
- 2005-11-15 ZA ZA200509253A patent/ZA200509253B/en unknown
- 2005-11-20 IL IL172064A patent/IL172064A/en active IP Right Grant
- 2005-12-20 CO CO05127734A patent/CO5650165A2/es active IP Right Grant
-
2006
- 2006-01-24 NO NO20060376A patent/NO20060376L/no not_active Application Discontinuation
- 2006-08-28 HK HK06109559A patent/HK1089170A1/xx not_active IP Right Cessation
- 2006-12-05 US US11/567,071 patent/US20070088032A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE414077T1 (de) | Verfahren zur herstellung von 1-ä(benzimidazol-1- yl)chinolin-8-ylüpiperidin-4-ylaminderivaten | |
| ATE515500T1 (de) | Verfahren zur herstellung von telmisartan | |
| ATE340819T1 (de) | Verfahren zur herstellung von polyamiden | |
| ATE408609T1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden | |
| DE602005026478D1 (de) | Verfahren zur Herstellung von dünnwandigen Isogittergehäusen | |
| DE60317690D1 (de) | Verfahren zur herstellung von valsartan | |
| DE60327788D1 (de) | Verfahren zur herstellung von polytrimethylenterephthalt-fasern | |
| ATE308524T1 (de) | Verfahren zur herstellung von aripiprazole | |
| ATE399157T1 (de) | Verfahren zur herstellung von telmisartan | |
| DE50308650D1 (de) | Verfahren zur herstellung von cellulosecarbamatformkörpern | |
| DE60330050D1 (de) | Verfahren zur herstellung von pyrimidinverbindungen | |
| ATE376997T1 (de) | Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten | |
| ATE456569T1 (de) | Verfahren zur herstellung von 6-alkyliden- penemderivaten | |
| ATE553103T1 (de) | Verfahren zur herstellung von (s)-pantoprazol | |
| ATE441662T1 (de) | Verfahren zur herstellung von echinocandinderivaten | |
| ATE453619T1 (de) | Verfahren zur herstellung von hydroperoxiden | |
| DE50303611D1 (de) | Verfahren zur herstellung von polyisobuten | |
| ATE466843T1 (de) | Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten | |
| ATE424892T1 (de) | Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins | |
| ATE402138T1 (de) | Verfahren zur herstellung von 2- aminoindanderivaten | |
| DE502004004318D1 (de) | Verfahren zur herstellung von metall-matrix-verbundwerkstoffen | |
| DE602004004677D1 (de) | Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine | |
| ATE549314T1 (de) | Verfahren zur herstellung von 4-aminochinazolinen | |
| ATE471941T1 (de) | Verfahren zur herstellung von thiazolopyrimidinen | |
| DE502004002810D1 (de) | Verfahren zur herstellung von copolymerisaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |